---
title: "In the early trading session on Thursday, U.S. stocks saw CRISPR Therapeutics decline by 1.7%, after"
description: "In the early trading session on Thursday, U.S. stocks saw CRISPR Therapeutics decline by 1.7%, after the company filed documents to sell up to $600 million in common stock, utilizing its existing publ"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261475194.md"
published_at: "2025-10-16T14:55:30.000Z"
---

# In the early trading session on Thursday, U.S. stocks saw CRISPR Therapeutics decline by 1.7%, after

> In the early trading session on Thursday, U.S. stocks saw CRISPR Therapeutics decline by 1.7%, after the company filed documents to sell up to $600 million in common stock, utilizing its existing public market sales agreement

In early trading on Thursday, shares of gene editing company CRISPR Therapeutics fell 1.7% after the company filed documents to sell up to $600 million in common stock, utilizing its existing public market sales agreement

### Related Stocks

- [CRSP.US - CRISPR Therap](https://longbridge.com/en/quote/CRSP.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| CRISPR 治疗｜10-K：2025 财年营收 3.51 百万美元不及预期 |  | [Link](https://longbridge.com/en/news/275815199.md) |
| CRISPR 治疗的首席财务官 Prasad Raju 报告了出售普通股的情况 | 根据监管文件，CRISPR Therapeutics AG 的首席财务官 Raju Prasad 报告了该公司普通股的出售。该文件可以通过 SEC 的系统 EDGAR 访问。此新闻简报由 Public Technologies 生成，并不构 | [Link](https://longbridge.com/en/news/270661626.md) |
| 美股的 “危险信号” | 本月标普 500 指数成分股在八个交易日内下跌 7% 或以上的股票数量已经超过 100 只，直逼 2022 年美股熊市的水平。 虽然这不像新冠疫情或关税危机期间那样极端，但该指标超过 100 通常意味着更大范围的下滑，而这种情况目前还没有发 | [Link](https://longbridge.com/en/news/276185288.md) |
| 美股盘前热门交易：Lunai Bioworks 盘前涨 9.42%；课标科技盘前跌 4.41% | Lunai Bioworks 盘前涨 9.42%；课标科技盘前跌 4.41%；Jiuzi 盘前涨 46.40%；Planet Image 盘前涨 33.33%；Theriva Biologics 盘前涨 28.13%。 | [Link](https://longbridge.com/en/news/276321115.md) |
| Indiqube Spaces 表示，发起人集团可能会从公开市场购买股票 | Indiqube Spaces Ltd：INDIQUBE SPACES LTD - 促销集团可能从公开市场购买股票 | [Link](https://longbridge.com/en/news/276043643.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.